|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0008976,
umls-concept:C0012634,
umls-concept:C0030705,
umls-concept:C0031809,
umls-concept:C0205412,
umls-concept:C0220825,
umls-concept:C0281481,
umls-concept:C0441655,
umls-concept:C0871261,
umls-concept:C0936012,
umls-concept:C1511726,
umls-concept:C1619966,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-5-20
|
|
pubmed:abstractText |
To assess the ability of efficacy measures that incorporate onset or sustainability to detect treatment effect or reflect patient satisfaction, using exploratory analyses of data from the ATTAIN (Abatacept Trial in Treatment of Anti-TNF INadequate Responders) trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-856X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
259-60
|
|
pubmed:meshHeading |
pubmed-meshheading:20483050-Antirheumatic Agents,
pubmed-meshheading:20483050-Arthritis, Rheumatoid,
pubmed-meshheading:20483050-Databases, Factual,
pubmed-meshheading:20483050-Humans,
pubmed-meshheading:20483050-Immunoconjugates,
pubmed-meshheading:20483050-Placebos,
pubmed-meshheading:20483050-Randomized Controlled Trials as Topic,
pubmed-meshheading:20483050-Severity of Illness Index,
pubmed-meshheading:20483050-Treatment Failure,
pubmed-meshheading:20483050-Tumor Necrosis Factor-alpha
|
|
pubmed:articleTitle |
Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial data.
|
|
pubmed:affiliation |
Rene Descartes University, Medicine Faculty, Hospital Cochin, Rheumatology B Department, Paris, France. maxime.dougados@cch.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
